(Q40974258)

25 September 2017

GM1 inhibits amyloid beta-protein-induced cytokine release (English)

1 reference

25 September 2017

Ariga T

1

1 reference

PubMed ID

9972868

25 September 2017

Yu RK

series ordinal

2

1 reference

25 September 2017

1 February 1999

1 reference

25 September 2017

Neurochemical Research

1 reference

25 September 2017

24

1 reference

25 September 2017

2

1 reference

25 September 2017

219-226

1 reference

https://scigraph.springernature.com/pub.10.1023/a:1022557920150

25 September 2017

0 references

cites work

Cortical distribution of gangliosides in Alzheimer's disease

1 reference

12 December 2020

Gangliosides suppress tumor necrosis factor production in human monocytes

1 reference

12 December 2020

1 reference

12 December 2020

Interleukin-6 and α-2-macroglobulin indicate an acute-phase state in Alzheimer's disease cortices

1 reference

12 December 2020

Elevated circulating tumor necrosis factor levels in Alzheimer's disease

1 reference

12 December 2020

In vitro aging of beta-amyloid protein causes peptide aggregation and neurotoxicity

1 reference

12 December 2020

Immunohistological study on brains of Alzheimer's disease using antibodies to fetal antigens, C-series gangliosides and microtubule-associated protein 5.

1 reference

12 December 2020

Interleukin-1 beta inhibits long-term potentiation in the CA3 region of mouse hippocampal slices.

1 reference

12 December 2020

Occurrence of neuropil threads in the senile human brain and in Alzheimer's disease: a third location of paired helical filaments outside of neurofibrillary tangles and neuritic plaques.

1 reference

12 December 2020

Interleukin 1 regulates synthesis of amyloid beta-protein precursor mRNA in human endothelial cells

1 reference

12 December 2020

Focusing on IL-1-promotion of beta-amyloid precursor protein synthesis as an early event in Alzheimer's disease.

1 reference

12 December 2020

Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease

1 reference

12 December 2020

Inhibition of lipopolysaccharide-induced monocyte interleukin 1 secretion by gangliosides

1 reference

12 December 2020

Thermotropic behavior of glycosphingolipids in aqueous dispersions.

1 reference

12 December 2020

Establishment and characterization of a human acute monocytic leukemia cell line (THP-1)

1 reference

12 December 2020

A convenient method for the preparation of asialo-GM1

1 reference

12 December 2020

Amyloid beta peptide potentiates cytokine secretion by interleukin-1 beta-activated human astrocytoma cells

1 reference

12 December 2020

GM1 ganglioside-bound amyloid beta-protein (A beta): a possible form of preamyloid in Alzheimer's disease.

1 reference

12 December 2020

Physiological production of the beta-amyloid protein and the mechanism of Alzheimer's disease

1 reference

12 December 2020

Ganglioside GM1 binds to the Trk protein and regulates receptor function

1 reference

12 December 2020

Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease

1 reference

12 December 2020

Activation of microglial cells by beta-amyloid protein and interferon-gamma.

1 reference

12 December 2020

Reciprocal control of inflammatory cytokines, IL-1 and IL-6, and β-amyloid production in cultures

1 reference

12 December 2020

Induction of immune system mediators in the hippocampal formation in Alzheimer's and Parkinson's diseases: selective effects on specific interleukins and interleukin receptors.

1 reference

12 December 2020

Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein

1 reference

12 December 2020

Prevention of apoptotic neuronal death by GM1 ganglioside. Involvement of Trk neurotrophin receptors.

1 reference

12 December 2020

Glycolipid composition of human cataractous lenses. Characterization of Lewisx glycolipids

1 reference

12 December 2020

Beta-amyloid neurotoxicity requires fibril formation and is inhibited by congo red.

1 reference

12 December 2020

Gangliosides--a new therapeutic agent against stroke and Alzheimer's disease

1 reference

12 December 2020

A model for beta-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer disease

1 reference

12 December 2020

Ultrastructural localization of gangliosides; GM1 is concentrated in caveolae

1 reference

12 December 2020

Thrombin attenuates neuronal cell death and modulates astrocyte reactivity induced by beta-amyloid in vitro

1 reference

12 December 2020

Beta-amyloid-induced cell toxicity: enhancement of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide-dependent cell death.

1 reference

12 December 2020

beta-Amyloid induces increased release of interleukin-1 beta from lipopolysaccharide-activated human monocytes

1 reference

12 December 2020

Amyloid beta-protein and the genetics of Alzheimer's disease

1 reference

12 December 2020

Characterization of the glycolipid associated with Alzheimer paired helical filaments

1 reference

12 December 2020

Interleukin-1 beta and interleukin-6 are elevated in the cerebrospinal fluid of Alzheimer's and de novo Parkinson's disease patients.

1 reference

12 December 2020

Interleukin-1 beta and tumor necrosis factor-alpha induce expression of alpha 1-antichymotrypsin in human astrocytoma cells by activation of nuclear factor-kappa B.

1 reference

12 December 2020

Brain-derived gangliosides regulate the cytokine production and proliferation of activated T cells.

1 reference

12 December 2020

Induction of rapid IL-1 beta mRNA degradation in THP-1 cells mediated through the AU-rich region in the 3'UTR by a radicicol analogue

1 reference

12 December 2020

Intracerebroventricular administration of GM1 ganglioside to presenile Alzheimer patients

1 reference

12 December 2020

The interaction between Alzheimer amyloid beta(1-40) peptide and ganglioside GM1-containing membranes

1 reference

12 December 2020

Quantitative analysis of bacterial toxin affinity and specificity for glycolipid receptors by surface plasmon resonance

1 reference

12 December 2020

Ganglioside GM1 enhances induction by nerve growth factor of a putative dimer of TrkA

1 reference

12 December 2020

Inhibition of the electrostatic interaction between beta-amyloid peptide and membranes prevents beta-amyloid-induced toxicity

1 reference

12 December 2020

Acceleration of amyloid fibril formation by specific binding of Abeta-(1-40) peptide to ganglioside-containing membrane vesicles

1 reference

12 December 2020

Interaction of Alzheimer beta-amyloid peptide(1-40) with lipid membranes

1 reference

12 December 2020

Structural transitions associated with the interaction of Alzheimer beta-amyloid peptides with gangliosides.

1 reference

12 December 2020

Identifiers

DOI

10.1023/A:1022557920150

1 reference

PubMed ID

9972868

Dimensions Publication ID

25 September 2017

0 references

1 reference

PubMed ID

9972868